Gene · 28882
Papers3,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design, Synthesis, and Biological Evaluation of C2-(N-Substituted Amino) Truncated 4'-Thioadenosine Derivatives as A2AAR and A3AR Dual Ligands. | ACS Med Chem Lett | 2025 | 41404002 | PubTator, text mining | PubMed |
| A novel multimodal pharmacologic approach using guanfacine, N-acetylcysteine, and donepezil in severe TBI: a case series. | Front Rehabil Sci | 2025 | 41211476 | PubTator, text mining | PubMed |
| Adenosine A3 Receptor and Its Potential Role in Cancer Treatment: A Narrative Review. | Cureus | 2025 | 41200621 | PubTator, text mining | PubMed |
| Adenosine Receptors in Neuroinflammation and Neurodegeneration. | Cells | 2025 | 41148800 | PubTator, text mining | PubMed |
| Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies. | Pharmacol Rev | 2025 | 41101027 | PubTator, text mining | PubMed |
| Structural Simplification from Tricyclic to Bicyclic Scaffolds: A Long-Term Investigation in the Field of Adenosine Receptor Antagonists. | Cells | 2025 | 41002445 | PubTator, text mining | PubMed |
| Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications. | Basic Clin Pharmacol Toxicol | 2025 | 41001763 | PubTator, text mining | PubMed |
| The role of intrinsically disordered domains in regulating G protein coupled receptor signaling. | bioRxiv | 2025 | 40964316 | PubTator, text mining | PubMed |
| Computational discovery of natural medicines targeting adenosine receptors for metabolic diseases. | Front Pharmacol | 2025 | 40963689 | PubTator, text mining | PubMed |
| The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma. | Biochim Biophys Acta Rev Cancer | 2025 | 40930263 | PubTator, text mining | PubMed |
| Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy? | Brain Commun | 2025 | 40904583 | PubTator, text mining | PubMed |
| Clustering within a single-component biomolecular condensate. | bioRxiv | 2025 | 40894708 | PubTator, text mining | PubMed |
| Cannabidiol biases A2A-CB2 receptor heteromer function by decoupling β-arrestin signaling from complex formation. | Biochem Pharmacol | 2025 | 40885321 | PubTator, text mining | PubMed |
| Damage response signaling by the extracellular adenosine pathway: control of infection outcome during host aging. | mSphere | 2025 | 40879364 | PubTator, text mining | PubMed |
| Adenosine receptors and acute kidney injury: perspectives for future therapy. | Purinergic Signal | 2025 | 40788370 | PubTator, text mining | PubMed |
| P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A/CD39/CD73 axis. | Cell Death Dis | 2025 | 40759630 | PubTator, text mining | PubMed |
| Programmable protein ligation on cell surfaces. | Nature | 2025 | 40739351 | PubTator, text mining | PubMed |
| Activation of Spinal Astrocyte α2A Adrenoceptors Protects Against Sepsis-Induced Heart Injury Through Inhibition of GABAergic Neuronal Necroptosis. | Adv Sci (Weinh) | 2025 | 40692211 | PubTator, text mining | PubMed |
| HIF-1α Stabilization Hampers the Chondrogenic Differentiation of Aged Bone Marrow Mesenchymal Stem Cells by Adenosine A2A/A2B Receptors Imbalance. | ACS Pharmacol Transl Sci | 2025 | 40672664 | PubTator, text mining | PubMed |
| Structure-guided engineering of snake toxins for selective modulation of adrenergic and muscarinic receptors. | Nat Commun | 2025 | 40659608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28882/papers?page=3